Zobrazeno 1 - 10
of 165
pro vyhledávání: '"Peter Wohlfahrt"'
Autor:
Peter Wohlfahrt, MD, PhD, Dominik Jenča, MD, Vojtěch Melenovský, MD, PhD, Jolana Mrázková, Mgr, Marek Šramko, MD, PhD, Martin Kotrč, MD, Michael Želízko, MD, Věra Adámková, MD, PhD, Francisco Lopez-Jimenez, MD, MSc, MBA, Jan Piťha, MD, PhD, Josef Kautzner, MD, PhD
Publikováno v:
Mayo Clinic Proceedings: Digital Health, Vol 2, Iss 3, Pp 352-360 (2024)
Objective: To evaluate the effect of smart device-based telerehabilitation on Vo2peak in patients after myocardial infarction. Patients and Methods: This was a pilot, single-center, randomized, cross-over study with a 3-month intervention. One month
Externí odkaz:
https://doaj.org/article/c54556d7a7594845a4ee28d4bb58a0e9
Autor:
Peter Wohlfahrt, Dominik Jenča, Vojtěch Melenovský, Josef Stehlik, John A. Spertus, Jolana Mrázková, Marek Šramko, Martin Kotrč, Michael Želízko, Věra Adámková, Jan Piťha, Josef Kautzner
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 2 (2024)
Background Heart failure is a common complication after myocardial infarction (MI) and is associated with increased mortality. Whether remote heart failure symptoms assessment after MI can improve risk stratification is unknown. The authors evaluated
Externí odkaz:
https://doaj.org/article/8e6d6cd5fcf94377a1ee6793519a8c0f
Autor:
Jan Benes, Martin Kotrc, Peter Wohlfahrt, Katerina Kroupova, Marek Tupy, Josef Kautzner, Vojtech Melenovsky
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
BackgroundRight ventricular (RV) function is currently being evaluated solely according to the properties of RV myocardium. We have tested a concept that in patients with heart failure with reduced ejection fraction (HFrEF), RV assessment should inte
Externí odkaz:
https://doaj.org/article/f0c064611d1246ab9f6d86c500aa3b31
Autor:
Jan Benes, Martin Kotrc, Katerina Kroupova, Peter Wohlfahrt, Jan Kovar, Janka Franekova, Marketa Hegarova, Lenka Hoskova, Eva Hoskova, Terezie Pelikanova, Petr Jarolim, Josef Kautzner, Vojtech Melenovsky
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract The role of metformin (MET) in the treatment of patients with advanced HFrEF and type 2 diabetes mellitus (DM) is not firmly established. We studied the impact of MET on metabolic profile, quality of life (QoL) and survival in these patients
Externí odkaz:
https://doaj.org/article/18cc780595cf44aca2cc2ffd0ab7a132
Autor:
Elisabetta Bianchini, Mai Tone Lønnebakken, Peter Wohlfahrt, Senol Piskin, Dimitrios Terentes‐Printzios, Jordi Alastruey, Andrea Guala
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 10 (2023)
Magnetic resonance imaging and computed tomography allow the characterization of arterial state and function with high confidence and thus play a key role in the understanding of arterial aging and its translation into the clinic. Decades of research
Externí odkaz:
https://doaj.org/article/b135ca7da6e74d2580bba10f284f573e
Autor:
Jan Latal, Michal Pazdernik, Maria Holicka, Radek Pelouch, Jiri Widimsky, Jiri Pudich, Radek Vancata, Michal Siranec, Kamila Blechova, Tadeas Butta, Marketa Mikulcova, Michal Mikulica, Peter Wohlfahrt, Martin Hutyra, Jan Precek
Publikováno v:
Biomedical Papers, Vol 166, Iss 2, Pp 168-172 (2022)
Aim. Understanding cardiac electronic device infective endocarditis epidemiology is essential for the management of this serious complication. Only monocentric and limited data have been published regarding patients in the Czech republic so far. The
Externí odkaz:
https://doaj.org/article/dbcaec93ab4f469f8716a611cb96376d
Autor:
Peter Wohlfahrt, Dominik Jenča, Vojtěch Melenovský, Petr Jarolím, Dana Dlouhá, Marek Šramko, Martin Kotrč, Michael Želízko, Jolana Mrázková, Jan Piťha, Věra Adámková, Josef Kautzner
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 6 (2023)
Background The hypocretin/orexin system has been shown to play a role in heart failure. Whether it also influences myocardial infarction (MI) outcomes is unknown. We evaluated the effect of the rs7767652 minor allele T associated with decreased trans
Externí odkaz:
https://doaj.org/article/44d740c12e5a41ca9cb54fe108d3ebbf
Autor:
Renata Cífková, Jan Bruthans, Peter Wohlfahrt, Alena Hrubeš Krajčoviechová, Pavel Šulc, Marie Jozífová, Lenka Eremiášová, Jan Pudil, Aleš Linhart, Jiří Widimský, Jan Filipovský, Otto Mayer, Rudolf Poledne, Petr Stávek, Věra Lánská, Larysa Strilchuk
Publikováno v:
Journal of Cardiovascular Development and Disease, Vol 10, Iss 8, p 328 (2023)
Background: Severe hypercholesterolemia is associated with an increase in the risk of developing atherosclerotic cardiovascular disease. The aim of this analysis was to assess longitudinal trends in severe dyslipidemia (defined as total cholesterol >
Externí odkaz:
https://doaj.org/article/1dceed81eda74206b84771d7e9372370
Autor:
Zuzana Tucanova, Peter Ivak, Peter Wohlfahrt, Marek Pol, Daniel Hlavacek, Miroslav Konarik, Ondrej Szarszoi, Ivan Netuka, Jan Pitha
Publikováno v:
ESC Heart Failure, Vol 8, Iss 5, Pp 4288-4295 (2021)
Abstract Aims Recipients of left ventricular assist devices (LVAD) are exposed to increased risk of adverse clinical events. One of the potential contributing factors is non‐pulsatile flow generated by LVAD. We evaluated the association of flow pat
Externí odkaz:
https://doaj.org/article/710e3f13c191446cac6d34c8cb366b62
Autor:
Peter Wohlfahrt, Dominik Jenča, Vojtěch Melenovský, Marek Šramko, Martin Kotrč, Michael Želízko, Jolana Mrázková, Věra Adámková, Jan Pitha, Josef Kautzner
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
BackgroundLeft ventricular ejection fraction (EF) is an independent predictor of adverse outcomes after myocardial infarction (MI). However, current data on trajectories and determinants of EF are scarce. The present study aimed to describe the epide
Externí odkaz:
https://doaj.org/article/de1df35f829b4df89220837b1c0e227f